Medical Care
Global iPSC Derived Cell Drugs Market Research Report 2025
- Mar 27, 25
- ID: 159040
- Pages: 73
- Figures: 76
- Views: 41
The global market for iPSC Derived Cell Drugs was valued at US$ 219 million in the year 2024 and is projected to reach a revised size of US$ 309 million by 2031, growing at a CAGR of 5.5% during the forecast period.
iPSC-derived cell drugs are drugs prepared using induced pluripotent stem cell (iPSC) technology. iPSCs are obtained by introducing specific transcription factors into somatic cells to reprogram them into pluripotent stem cells. These pluripotent stem cells have the potential to differentiate into various cell types and can therefore be used to prepare cell drugs for the treatment of specific diseases. iPSC-derived cell drugs have broad application prospects in the treatment of degenerative diseases, tissue repair, and other areas. By directing the differentiation of iPSCs into specific types of cells, such as neurons and cardiomyocytes, personalized cell replacement therapies can be provided to patients, thereby restoring the function of damaged tissues.
North American market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for iPSC Derived Cell Drugs in Anti-Inflammatory Repair is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of iPSC Derived Cell Drugs include Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for iPSC Derived Cell Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding iPSC Derived Cell Drugs.
The iPSC Derived Cell Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global iPSC Derived Cell Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the iPSC Derived Cell Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai UniXell Biotechnology
HELP Therapeutics
Hopstem Biotechnology
Nuwacell
Allele Biotech
BlueRock Therapeutics
Century Therapeutics
Fate Therapeutics
Cellino
Xellsmart
Segment by Type
Autologous iPSC Derived Cell Drugs
Universal iPSC Derived Cell Drugs
Segment by Application
Anti-Inflammatory Repair
Tumor Immunity
Regenerative Medicine
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of iPSC Derived Cell Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
iPSC-derived cell drugs are drugs prepared using induced pluripotent stem cell (iPSC) technology. iPSCs are obtained by introducing specific transcription factors into somatic cells to reprogram them into pluripotent stem cells. These pluripotent stem cells have the potential to differentiate into various cell types and can therefore be used to prepare cell drugs for the treatment of specific diseases. iPSC-derived cell drugs have broad application prospects in the treatment of degenerative diseases, tissue repair, and other areas. By directing the differentiation of iPSCs into specific types of cells, such as neurons and cardiomyocytes, personalized cell replacement therapies can be provided to patients, thereby restoring the function of damaged tissues.
North American market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for iPSC Derived Cell Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for iPSC Derived Cell Drugs in Anti-Inflammatory Repair is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of iPSC Derived Cell Drugs include Shanghai UniXell Biotechnology, HELP Therapeutics, Hopstem Biotechnology, Nuwacell, Allele Biotech, BlueRock Therapeutics, Century Therapeutics, Fate Therapeutics, Cellino, Xellsmart, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for iPSC Derived Cell Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding iPSC Derived Cell Drugs.
The iPSC Derived Cell Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global iPSC Derived Cell Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the iPSC Derived Cell Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai UniXell Biotechnology
HELP Therapeutics
Hopstem Biotechnology
Nuwacell
Allele Biotech
BlueRock Therapeutics
Century Therapeutics
Fate Therapeutics
Cellino
Xellsmart
Segment by Type
Autologous iPSC Derived Cell Drugs
Universal iPSC Derived Cell Drugs
Segment by Application
Anti-Inflammatory Repair
Tumor Immunity
Regenerative Medicine
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of iPSC Derived Cell Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global iPSC Derived Cell Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous iPSC Derived Cell Drugs
1.2.3 Universal iPSC Derived Cell Drugs
1.3 Market by Application
1.3.1 Global iPSC Derived Cell Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Anti-Inflammatory Repair
1.3.3 Tumor Immunity
1.3.4 Regenerative Medicine
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global iPSC Derived Cell Drugs Market Perspective (2020-2031)
2.2 Global iPSC Derived Cell Drugs Growth Trends by Region
2.2.1 Global iPSC Derived Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 iPSC Derived Cell Drugs Historic Market Size by Region (2020-2025)
2.2.3 iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031)
2.3 iPSC Derived Cell Drugs Market Dynamics
2.3.1 iPSC Derived Cell Drugs Industry Trends
2.3.2 iPSC Derived Cell Drugs Market Drivers
2.3.3 iPSC Derived Cell Drugs Market Challenges
2.3.4 iPSC Derived Cell Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top iPSC Derived Cell Drugs Players by Revenue
3.1.1 Global Top iPSC Derived Cell Drugs Players by Revenue (2020-2025)
3.1.2 Global iPSC Derived Cell Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top iPSC Derived Cell Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by iPSC Derived Cell Drugs Revenue
3.4 Global iPSC Derived Cell Drugs Market Concentration Ratio
3.4.1 Global iPSC Derived Cell Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by iPSC Derived Cell Drugs Revenue in 2024
3.5 Global Key Players of iPSC Derived Cell Drugs Head office and Area Served
3.6 Global Key Players of iPSC Derived Cell Drugs, Product and Application
3.7 Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 iPSC Derived Cell Drugs Breakdown Data by Type
4.1 Global iPSC Derived Cell Drugs Historic Market Size by Type (2020-2025)
4.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031)
5 iPSC Derived Cell Drugs Breakdown Data by Application
5.1 Global iPSC Derived Cell Drugs Historic Market Size by Application (2020-2025)
5.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America iPSC Derived Cell Drugs Market Size (2020-2031)
6.2 North America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America iPSC Derived Cell Drugs Market Size by Country (2020-2025)
6.4 North America iPSC Derived Cell Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe iPSC Derived Cell Drugs Market Size (2020-2031)
7.2 Europe iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025)
7.4 Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific iPSC Derived Cell Drugs Market Size (2020-2031)
8.2 Asia-Pacific iPSC Derived Cell Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America iPSC Derived Cell Drugs Market Size (2020-2031)
9.2 Latin America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025)
9.4 Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa iPSC Derived Cell Drugs Market Size (2020-2031)
10.2 Middle East & Africa iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai UniXell Biotechnology
11.1.1 Shanghai UniXell Biotechnology Company Details
11.1.2 Shanghai UniXell Biotechnology Business Overview
11.1.3 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Introduction
11.1.4 Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.1.5 Shanghai UniXell Biotechnology Recent Development
11.2 HELP Therapeutics
11.2.1 HELP Therapeutics Company Details
11.2.2 HELP Therapeutics Business Overview
11.2.3 HELP Therapeutics iPSC Derived Cell Drugs Introduction
11.2.4 HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.2.5 HELP Therapeutics Recent Development
11.3 Hopstem Biotechnology
11.3.1 Hopstem Biotechnology Company Details
11.3.2 Hopstem Biotechnology Business Overview
11.3.3 Hopstem Biotechnology iPSC Derived Cell Drugs Introduction
11.3.4 Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.3.5 Hopstem Biotechnology Recent Development
11.4 Nuwacell
11.4.1 Nuwacell Company Details
11.4.2 Nuwacell Business Overview
11.4.3 Nuwacell iPSC Derived Cell Drugs Introduction
11.4.4 Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.4.5 Nuwacell Recent Development
11.5 Allele Biotech
11.5.1 Allele Biotech Company Details
11.5.2 Allele Biotech Business Overview
11.5.3 Allele Biotech iPSC Derived Cell Drugs Introduction
11.5.4 Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.5.5 Allele Biotech Recent Development
11.6 BlueRock Therapeutics
11.6.1 BlueRock Therapeutics Company Details
11.6.2 BlueRock Therapeutics Business Overview
11.6.3 BlueRock Therapeutics iPSC Derived Cell Drugs Introduction
11.6.4 BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.6.5 BlueRock Therapeutics Recent Development
11.7 Century Therapeutics
11.7.1 Century Therapeutics Company Details
11.7.2 Century Therapeutics Business Overview
11.7.3 Century Therapeutics iPSC Derived Cell Drugs Introduction
11.7.4 Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.7.5 Century Therapeutics Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics iPSC Derived Cell Drugs Introduction
11.8.4 Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.8.5 Fate Therapeutics Recent Development
11.9 Cellino
11.9.1 Cellino Company Details
11.9.2 Cellino Business Overview
11.9.3 Cellino iPSC Derived Cell Drugs Introduction
11.9.4 Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.9.5 Cellino Recent Development
11.10 Xellsmart
11.10.1 Xellsmart Company Details
11.10.2 Xellsmart Business Overview
11.10.3 Xellsmart iPSC Derived Cell Drugs Introduction
11.10.4 Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.10.5 Xellsmart Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global iPSC Derived Cell Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous iPSC Derived Cell Drugs
1.2.3 Universal iPSC Derived Cell Drugs
1.3 Market by Application
1.3.1 Global iPSC Derived Cell Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Anti-Inflammatory Repair
1.3.3 Tumor Immunity
1.3.4 Regenerative Medicine
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global iPSC Derived Cell Drugs Market Perspective (2020-2031)
2.2 Global iPSC Derived Cell Drugs Growth Trends by Region
2.2.1 Global iPSC Derived Cell Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 iPSC Derived Cell Drugs Historic Market Size by Region (2020-2025)
2.2.3 iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031)
2.3 iPSC Derived Cell Drugs Market Dynamics
2.3.1 iPSC Derived Cell Drugs Industry Trends
2.3.2 iPSC Derived Cell Drugs Market Drivers
2.3.3 iPSC Derived Cell Drugs Market Challenges
2.3.4 iPSC Derived Cell Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top iPSC Derived Cell Drugs Players by Revenue
3.1.1 Global Top iPSC Derived Cell Drugs Players by Revenue (2020-2025)
3.1.2 Global iPSC Derived Cell Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Top iPSC Derived Cell Drugs Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by iPSC Derived Cell Drugs Revenue
3.4 Global iPSC Derived Cell Drugs Market Concentration Ratio
3.4.1 Global iPSC Derived Cell Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by iPSC Derived Cell Drugs Revenue in 2024
3.5 Global Key Players of iPSC Derived Cell Drugs Head office and Area Served
3.6 Global Key Players of iPSC Derived Cell Drugs, Product and Application
3.7 Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 iPSC Derived Cell Drugs Breakdown Data by Type
4.1 Global iPSC Derived Cell Drugs Historic Market Size by Type (2020-2025)
4.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031)
5 iPSC Derived Cell Drugs Breakdown Data by Application
5.1 Global iPSC Derived Cell Drugs Historic Market Size by Application (2020-2025)
5.2 Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America iPSC Derived Cell Drugs Market Size (2020-2031)
6.2 North America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America iPSC Derived Cell Drugs Market Size by Country (2020-2025)
6.4 North America iPSC Derived Cell Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe iPSC Derived Cell Drugs Market Size (2020-2031)
7.2 Europe iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025)
7.4 Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific iPSC Derived Cell Drugs Market Size (2020-2031)
8.2 Asia-Pacific iPSC Derived Cell Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America iPSC Derived Cell Drugs Market Size (2020-2031)
9.2 Latin America iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025)
9.4 Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa iPSC Derived Cell Drugs Market Size (2020-2031)
10.2 Middle East & Africa iPSC Derived Cell Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai UniXell Biotechnology
11.1.1 Shanghai UniXell Biotechnology Company Details
11.1.2 Shanghai UniXell Biotechnology Business Overview
11.1.3 Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Introduction
11.1.4 Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.1.5 Shanghai UniXell Biotechnology Recent Development
11.2 HELP Therapeutics
11.2.1 HELP Therapeutics Company Details
11.2.2 HELP Therapeutics Business Overview
11.2.3 HELP Therapeutics iPSC Derived Cell Drugs Introduction
11.2.4 HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.2.5 HELP Therapeutics Recent Development
11.3 Hopstem Biotechnology
11.3.1 Hopstem Biotechnology Company Details
11.3.2 Hopstem Biotechnology Business Overview
11.3.3 Hopstem Biotechnology iPSC Derived Cell Drugs Introduction
11.3.4 Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.3.5 Hopstem Biotechnology Recent Development
11.4 Nuwacell
11.4.1 Nuwacell Company Details
11.4.2 Nuwacell Business Overview
11.4.3 Nuwacell iPSC Derived Cell Drugs Introduction
11.4.4 Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.4.5 Nuwacell Recent Development
11.5 Allele Biotech
11.5.1 Allele Biotech Company Details
11.5.2 Allele Biotech Business Overview
11.5.3 Allele Biotech iPSC Derived Cell Drugs Introduction
11.5.4 Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.5.5 Allele Biotech Recent Development
11.6 BlueRock Therapeutics
11.6.1 BlueRock Therapeutics Company Details
11.6.2 BlueRock Therapeutics Business Overview
11.6.3 BlueRock Therapeutics iPSC Derived Cell Drugs Introduction
11.6.4 BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.6.5 BlueRock Therapeutics Recent Development
11.7 Century Therapeutics
11.7.1 Century Therapeutics Company Details
11.7.2 Century Therapeutics Business Overview
11.7.3 Century Therapeutics iPSC Derived Cell Drugs Introduction
11.7.4 Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.7.5 Century Therapeutics Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics iPSC Derived Cell Drugs Introduction
11.8.4 Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.8.5 Fate Therapeutics Recent Development
11.9 Cellino
11.9.1 Cellino Company Details
11.9.2 Cellino Business Overview
11.9.3 Cellino iPSC Derived Cell Drugs Introduction
11.9.4 Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.9.5 Cellino Recent Development
11.10 Xellsmart
11.10.1 Xellsmart Company Details
11.10.2 Xellsmart Business Overview
11.10.3 Xellsmart iPSC Derived Cell Drugs Introduction
11.10.4 Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025)
11.10.5 Xellsmart Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global iPSC Derived Cell Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous iPSC Derived Cell Drugs
Table 3. Key Players of Universal iPSC Derived Cell Drugs
Table 4. Global iPSC Derived Cell Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global iPSC Derived Cell Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global iPSC Derived Cell Drugs Market Share by Region (2020-2025)
Table 8. Global iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global iPSC Derived Cell Drugs Market Share by Region (2026-2031)
Table 10. iPSC Derived Cell Drugs Market Trends
Table 11. iPSC Derived Cell Drugs Market Drivers
Table 12. iPSC Derived Cell Drugs Market Challenges
Table 13. iPSC Derived Cell Drugs Market Restraints
Table 14. Global iPSC Derived Cell Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global iPSC Derived Cell Drugs Market Share by Players (2020-2025)
Table 16. Global Top iPSC Derived Cell Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Derived Cell Drugs as of 2024)
Table 17. Ranking of Global Top iPSC Derived Cell Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by iPSC Derived Cell Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of iPSC Derived Cell Drugs, Headquarters and Area Served
Table 20. Global Key Players of iPSC Derived Cell Drugs, Product and Application
Table 21. Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global iPSC Derived Cell Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global iPSC Derived Cell Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific iPSC Derived Cell Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Shanghai UniXell Biotechnology Company Details
Table 47. Shanghai UniXell Biotechnology Business Overview
Table 48. Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Product
Table 49. Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 50. Shanghai UniXell Biotechnology Recent Development
Table 51. HELP Therapeutics Company Details
Table 52. HELP Therapeutics Business Overview
Table 53. HELP Therapeutics iPSC Derived Cell Drugs Product
Table 54. HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 55. HELP Therapeutics Recent Development
Table 56. Hopstem Biotechnology Company Details
Table 57. Hopstem Biotechnology Business Overview
Table 58. Hopstem Biotechnology iPSC Derived Cell Drugs Product
Table 59. Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 60. Hopstem Biotechnology Recent Development
Table 61. Nuwacell Company Details
Table 62. Nuwacell Business Overview
Table 63. Nuwacell iPSC Derived Cell Drugs Product
Table 64. Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 65. Nuwacell Recent Development
Table 66. Allele Biotech Company Details
Table 67. Allele Biotech Business Overview
Table 68. Allele Biotech iPSC Derived Cell Drugs Product
Table 69. Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 70. Allele Biotech Recent Development
Table 71. BlueRock Therapeutics Company Details
Table 72. BlueRock Therapeutics Business Overview
Table 73. BlueRock Therapeutics iPSC Derived Cell Drugs Product
Table 74. BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 75. BlueRock Therapeutics Recent Development
Table 76. Century Therapeutics Company Details
Table 77. Century Therapeutics Business Overview
Table 78. Century Therapeutics iPSC Derived Cell Drugs Product
Table 79. Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 80. Century Therapeutics Recent Development
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics iPSC Derived Cell Drugs Product
Table 84. Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 85. Fate Therapeutics Recent Development
Table 86. Cellino Company Details
Table 87. Cellino Business Overview
Table 88. Cellino iPSC Derived Cell Drugs Product
Table 89. Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 90. Cellino Recent Development
Table 91. Xellsmart Company Details
Table 92. Xellsmart Business Overview
Table 93. Xellsmart iPSC Derived Cell Drugs Product
Table 94. Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 95. Xellsmart Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. iPSC Derived Cell Drugs Picture
Figure 2. Global iPSC Derived Cell Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global iPSC Derived Cell Drugs Market Share by Type: 2024 VS 2031
Figure 4. Autologous iPSC Derived Cell Drugs Features
Figure 5. Universal iPSC Derived Cell Drugs Features
Figure 6. Global iPSC Derived Cell Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global iPSC Derived Cell Drugs Market Share by Application: 2024 VS 2031
Figure 8. Anti-Inflammatory Repair Case Studies
Figure 9. Tumor Immunity Case Studies
Figure 10. Regenerative Medicine Case Studies
Figure 11. Others Case Studies
Figure 12. iPSC Derived Cell Drugs Report Years Considered
Figure 13. Global iPSC Derived Cell Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global iPSC Derived Cell Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global iPSC Derived Cell Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global iPSC Derived Cell Drugs Market Share by Players in 2024
Figure 17. Global iPSC Derived Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by iPSC Derived Cell Drugs Revenue in 2024
Figure 19. North America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 21. United States iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 25. Germany iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific iPSC Derived Cell Drugs Market Share by Region (2020-2031)
Figure 33. China iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 41. Mexico iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 45. Turkey iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Shanghai UniXell Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 49. HELP Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 50. Hopstem Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 51. Nuwacell Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 52. Allele Biotech Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 53. BlueRock Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 54. Century Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 55. Fate Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 56. Cellino Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 57. Xellsmart Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global iPSC Derived Cell Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous iPSC Derived Cell Drugs
Table 3. Key Players of Universal iPSC Derived Cell Drugs
Table 4. Global iPSC Derived Cell Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global iPSC Derived Cell Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global iPSC Derived Cell Drugs Market Share by Region (2020-2025)
Table 8. Global iPSC Derived Cell Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global iPSC Derived Cell Drugs Market Share by Region (2026-2031)
Table 10. iPSC Derived Cell Drugs Market Trends
Table 11. iPSC Derived Cell Drugs Market Drivers
Table 12. iPSC Derived Cell Drugs Market Challenges
Table 13. iPSC Derived Cell Drugs Market Restraints
Table 14. Global iPSC Derived Cell Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global iPSC Derived Cell Drugs Market Share by Players (2020-2025)
Table 16. Global Top iPSC Derived Cell Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in iPSC Derived Cell Drugs as of 2024)
Table 17. Ranking of Global Top iPSC Derived Cell Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by iPSC Derived Cell Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of iPSC Derived Cell Drugs, Headquarters and Area Served
Table 20. Global Key Players of iPSC Derived Cell Drugs, Product and Application
Table 21. Global Key Players of iPSC Derived Cell Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global iPSC Derived Cell Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global iPSC Derived Cell Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global iPSC Derived Cell Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global iPSC Derived Cell Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global iPSC Derived Cell Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global iPSC Derived Cell Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific iPSC Derived Cell Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific iPSC Derived Cell Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa iPSC Derived Cell Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa iPSC Derived Cell Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Shanghai UniXell Biotechnology Company Details
Table 47. Shanghai UniXell Biotechnology Business Overview
Table 48. Shanghai UniXell Biotechnology iPSC Derived Cell Drugs Product
Table 49. Shanghai UniXell Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 50. Shanghai UniXell Biotechnology Recent Development
Table 51. HELP Therapeutics Company Details
Table 52. HELP Therapeutics Business Overview
Table 53. HELP Therapeutics iPSC Derived Cell Drugs Product
Table 54. HELP Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 55. HELP Therapeutics Recent Development
Table 56. Hopstem Biotechnology Company Details
Table 57. Hopstem Biotechnology Business Overview
Table 58. Hopstem Biotechnology iPSC Derived Cell Drugs Product
Table 59. Hopstem Biotechnology Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 60. Hopstem Biotechnology Recent Development
Table 61. Nuwacell Company Details
Table 62. Nuwacell Business Overview
Table 63. Nuwacell iPSC Derived Cell Drugs Product
Table 64. Nuwacell Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 65. Nuwacell Recent Development
Table 66. Allele Biotech Company Details
Table 67. Allele Biotech Business Overview
Table 68. Allele Biotech iPSC Derived Cell Drugs Product
Table 69. Allele Biotech Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 70. Allele Biotech Recent Development
Table 71. BlueRock Therapeutics Company Details
Table 72. BlueRock Therapeutics Business Overview
Table 73. BlueRock Therapeutics iPSC Derived Cell Drugs Product
Table 74. BlueRock Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 75. BlueRock Therapeutics Recent Development
Table 76. Century Therapeutics Company Details
Table 77. Century Therapeutics Business Overview
Table 78. Century Therapeutics iPSC Derived Cell Drugs Product
Table 79. Century Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 80. Century Therapeutics Recent Development
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics iPSC Derived Cell Drugs Product
Table 84. Fate Therapeutics Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 85. Fate Therapeutics Recent Development
Table 86. Cellino Company Details
Table 87. Cellino Business Overview
Table 88. Cellino iPSC Derived Cell Drugs Product
Table 89. Cellino Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 90. Cellino Recent Development
Table 91. Xellsmart Company Details
Table 92. Xellsmart Business Overview
Table 93. Xellsmart iPSC Derived Cell Drugs Product
Table 94. Xellsmart Revenue in iPSC Derived Cell Drugs Business (2020-2025) & (US$ Million)
Table 95. Xellsmart Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. iPSC Derived Cell Drugs Picture
Figure 2. Global iPSC Derived Cell Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global iPSC Derived Cell Drugs Market Share by Type: 2024 VS 2031
Figure 4. Autologous iPSC Derived Cell Drugs Features
Figure 5. Universal iPSC Derived Cell Drugs Features
Figure 6. Global iPSC Derived Cell Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global iPSC Derived Cell Drugs Market Share by Application: 2024 VS 2031
Figure 8. Anti-Inflammatory Repair Case Studies
Figure 9. Tumor Immunity Case Studies
Figure 10. Regenerative Medicine Case Studies
Figure 11. Others Case Studies
Figure 12. iPSC Derived Cell Drugs Report Years Considered
Figure 13. Global iPSC Derived Cell Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global iPSC Derived Cell Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global iPSC Derived Cell Drugs Market Share by Region: 2024 VS 2031
Figure 16. Global iPSC Derived Cell Drugs Market Share by Players in 2024
Figure 17. Global iPSC Derived Cell Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by iPSC Derived Cell Drugs Revenue in 2024
Figure 19. North America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 21. United States iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 25. Germany iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific iPSC Derived Cell Drugs Market Share by Region (2020-2031)
Figure 33. China iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 41. Mexico iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa iPSC Derived Cell Drugs Market Share by Country (2020-2031)
Figure 45. Turkey iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE iPSC Derived Cell Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Shanghai UniXell Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 49. HELP Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 50. Hopstem Biotechnology Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 51. Nuwacell Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 52. Allele Biotech Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 53. BlueRock Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 54. Century Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 55. Fate Therapeutics Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 56. Cellino Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 57. Xellsmart Revenue Growth Rate in iPSC Derived Cell Drugs Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232